Discover the IN-4-AHA project outputs – Living Lab testing and innovation scale-up playbook (WP4 – D4.1)

This article is part of a series of editorials dedicated to discovering, at-a-glance, some of the most recent project outputs of the IN-4-AHA project.

In this article, we will focus on IN-4-AHA Living Lab testing and innovation scale-up playbook (D4.1), produced as part of the activities of Work Package 4 – Service testing and adoption.

To learn more about the playbook, we asked three key questions to Mervi Rajahonka, Senior Consultant at South-Eastern Finland University of Applied Sciences Xamk, lead partner for this IN-4-AHA product.

What is the IN-4-AHA Playbook? What is its focus?

The living Lab testing and innovation scale-up playbook offers guidance on how to test innovative active and healthy ageing (AHA) solutions in living labs and how to scale them up.

 The playbook builds on two approaches – design thinking and lean startup – which are based on the idea that the co-creation of innovations with customers and end-users leads to better results.

 Moreover, creating valuable and scalable innovations in the AHA field requires multidisciplinary collaboration of a wide range of stakeholders. One of the environments bringing stakeholders together and supporting such collaboration is represented by living labs.

Who is the IN-4-AHA Playbook intended for?

The playbook is intended for startups but also for all parties interested in living lab testing and scaling up AHA innovations.

What is the added value of this deliverable? 

One of the main objectives of living labs is to minimise the innovation risk and maximise the likelihood of successful market entry.

For AHA innovations, using this opportunity to test ideas and solutions is particularly important because the health and care systems, practices and legislation are different in each EU country. The playbook offers guidance on how to test innovative AHA solutions for scaling up. It also offers tips and practical tools for self-assessment.

Do you want to check out the IN-4-AHA Living Lab testing and innovation scale-up playbook? You can access it directly on our website here or download it in document format here. And do not miss the opportunity to visit our page to discover all other IN-4-AHA key outputs.

Want to know more about IN-4-AHA and its outcomes, register now for the Final Conference of the project, taking place in Tallinn (and online) on 7th December 2022! Seats are limited, check out the event agenda and register now!

Join the EIT Health Matchmaking event in Tallinn, 5 – 6 December​

Just before the IN-4-AHA Final Conference on 7th December, Tallinn will host another key event for innovation in health.

 IN-4-AHA’s Consortium Partner EIT Health Scandinavia is excited to invite you to the final EIT Health Matchmaking event of the year, this time focused on how to define new models to deliver healthcare, and implementing robust analysis of databases that are already in place. At the centre of this will be the concept of value-based healthcare, where success measures are based on patient outcomes and the shift from treatment to prevention. 

The two flagships and challenges are: 

  • New models to deliver healthcare
  • Harnessing the full potential of health data for innovation

 

Why attending?

  • Be inspired by experts in High Value Care, new healthcare delivery models and health data for innovation and discover some best in practise use cases 
  • Hear from leading biobanks and health registers – find out how to access data and samples and discover some best in practise use cases  
  • Matchmake and schedule your 1-2-1 meetings to discuss current project proposals and plan for future ones 
  • Meet the EIT Health team to learn more about the two flagships calls  
  • Ask further questions and receive bespoke support from EIT Health about our call for projects, our platforms or any other EIT Health initiatives.  

 

Where: Radisson Collection Hotel, Tallinn 

Click here to see the full agenda and REGISTER NOW